These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19292014)

  • 21. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
    Herrmann HC; Lu J; Brodie BR; Armstrong PW; Montalescot G; Betriu A; Neuman FJ; Effron MB; Barnathan ES; Topol EJ; Ellis SG;
    JACC Cardiovasc Interv; 2009 Oct; 2(10):917-24. PubMed ID: 19850249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
    Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase.
    Merlini PA; Repetto A; Andreoli AM; Ricci S; Lombardi A; Finardi A; Dipasquale G; Lamponi M; Mannucci PM; Ardissino D
    Am J Cardiol; 2004 Jan; 93(2):195-8. PubMed ID: 14715345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction].
    Savonitto S
    G Ital Cardiol (Rome); 2009 Jun; 10(6):364-5. PubMed ID: 19603607
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful Treatment of Myocardial Infarction in an Infant With Kawasaki Disease.
    Jone PN; Tapia D; Davidson J; Fagan TE; Browne L; Ing RJ; Kay J
    Semin Cardiothorac Vasc Anesth; 2015 Sep; 19(3):255-9. PubMed ID: 25700695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
    Hobbach HP; Schuster P
    Z Kardiol; 2003 Mar; 92(3):213-8. PubMed ID: 12658467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confusion in reperfusion.
    Gibson CM
    J Am Coll Cardiol; 2003 Oct; 42(7):1186-7. PubMed ID: 14522477
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 30. Revascularization techniques in acute myocardial infarction.
    Gorman RC; Gorman JH
    N Engl J Med; 2000 Dec; 343(24):1815. PubMed ID: 11185605
    [No Abstract]   [Full Text] [Related]  

  • 31. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute stroke -- an overview].
    Georgiadis D; Michel P; Bogousslavsky J; Baumgartner RW
    Ther Umsch; 2003 Sep; 60(9):509-20. PubMed ID: 14579619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New thrombolytic regimens in acute myocardial infarction.
    Hobbach HP; Schuster P
    Lancet; 2001 Dec; 358(9298):2080. PubMed ID: 11755640
    [No Abstract]   [Full Text] [Related]  

  • 34. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
    Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
    Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
    De Luca G; Suryapranata H; Stone GW; Antoniucci D; Tcheng JE; Neumann FJ; Bonizzoni E; Topol EJ; Chiariello M
    J Am Coll Cardiol; 2006 Feb; 47(3):685-6. PubMed ID: 16458158
    [No Abstract]   [Full Text] [Related]  

  • 36. PCI at non-PCI centres: immediate or rescue?
    Danchin N; Armstrong PW
    Lancet; 2008 Feb; 371(9612):534-6. PubMed ID: 18280311
    [No Abstract]   [Full Text] [Related]  

  • 37. Abciximab in the treatment of ST-segment elevation myocardial infarction.
    Tan DS; Sim DK; Chan ES; Tan RS
    JAMA; 2005 Oct; 294(14):1760-1; author reply 1761. PubMed ID: 16219877
    [No Abstract]   [Full Text] [Related]  

  • 38. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries.
    Askari AT; Lincoff AM
    Cleve Clin J Med; 2002 Jul; 69(7):554-60. PubMed ID: 12109639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis.
    Szabo S; Etzel D; Ehlers R; Walter T; Kazmaier S; Helber U; Beyer ME; Hoffmeister HM
    Drugs Exp Clin Res; 2004; 30(2):47-54. PubMed ID: 15272642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.